A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles
- PMID: 21073837
- DOI: 10.5414/npp29351
A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles
Abstract
Neutral lipid storage disease with myopathy (NLSDM) is a type of lipid storage myopathy arising due to a mutation in the PNPLA2 gene encoding an adipose triglyceride lipase responsible for the degradation of intracellular triglycerides. Herein, we report the cases of two siblings manifesting slowly progressive proximal and distal limb weakness in adulthood. One of the patients had dilated cardiomyopathy, hearing loss and short stature. Muscle specimens of the 2 patients revealed muscular dystrophic features with massive lipid droplets and numerous rimmed vacuoles in the fibers. A novel homozygous mutation IVS2+1G > A in the PNPLA2 gene was identified in the 2 cases, but not in the healthy familial individuals. The presence of massive lipid droplets with muscular dystrophic changes and rimmed vacuoles in muscle fibers might be one of the characteristic pathological changes of NLSDM.
Similar articles
-
Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.Clin Neurol Neurosurg. 2018 May;168:102-107. doi: 10.1016/j.clineuro.2018.03.001. Epub 2018 Mar 5. Clin Neurol Neurosurg. 2018. PMID: 29539587
-
Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy.Clin Neuropathol. 2019 Jul/Aug;38(4):157-167. doi: 10.5414/NP301159. Clin Neuropathol. 2019. PMID: 30738494
-
A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.Neuromuscul Disord. 2014 Jul;24(7):634-41. doi: 10.1016/j.nmd.2014.04.001. Epub 2014 Apr 21. Neuromuscul Disord. 2014. PMID: 24836204 Review.
-
Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.Biochem Biophys Res Commun. 2013 Jan 4;430(1):241-4. doi: 10.1016/j.bbrc.2012.10.127. Epub 2012 Nov 9. Biochem Biophys Res Commun. 2013. PMID: 23146629
-
Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation.Muscle Nerve. 2016 Apr;53(4):644-8. doi: 10.1002/mus.24983. Epub 2016 Feb 22. Muscle Nerve. 2016. PMID: 26600210 Review.
Cited by
-
Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases.J Lipid Res. 2012 Jan;53(1):4-27. doi: 10.1194/jlr.R012120. Epub 2011 Nov 7. J Lipid Res. 2012. PMID: 22065858 Free PMC article. Review.
-
A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy.Genes Dis. 2019 Jul 29;8(1):73-78. doi: 10.1016/j.gendis.2019.07.006. eCollection 2021 Jan. Genes Dis. 2019. PMID: 33569515 Free PMC article.
-
Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease.Dermatoendocrinol. 2011 Apr;3(2):77-83. doi: 10.4161/derm.3.2.15472. Epub 2011 Apr 1. Dermatoendocrinol. 2011. PMID: 21695016 Free PMC article.
-
Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.Hum Mol Genet. 2012 Dec 15;21(24):5318-28. doi: 10.1093/hmg/dds388. Epub 2012 Sep 17. Hum Mol Genet. 2012. PMID: 22990388 Free PMC article.
-
Symptomatic lipid storage in carriers for the PNPLA2 gene.Eur J Hum Genet. 2013 Aug;21(8):807-15. doi: 10.1038/ejhg.2012.256. Epub 2012 Dec 12. Eur J Hum Genet. 2013. PMID: 23232698 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical